Nuo Therapeutics, Inc. (AURX) | Jive Data

Google Sheets Add-onSheets Account

Profile Financials SEC Filings Insider Transactions Ownership

Loading AURX…

Nuo Therapeutics, Inc. (AURX) | Jive Data

Google Sheets Add-onSheets Account

Profile Financials SEC Filings Insider Transactions Ownership

SEC filing

Nuo Therapeutics, Inc.

AURX · CIK 1091596

4 · Aug 28, 2026 · Director, CEO/CFO JORDEN DAVID EMERSON was granted 8,773 shares at $1.09/share ($9,539)

4

Director, CEO/CFO JORDEN DAVID EMERSON was granted 8,773 shares at $1.09/share ($9,539)

Filed: Aug 28, 2026
Period: Aug 27, 2026
Accession: 0001437749-26-029236
Filer: Nuo Therapeutics, Inc.

View on SEC.gov All SEC filings

Filing document

FORM 4

xslF345X06/rdgdoc.xmlSEC.gov

Other files

Graphics and non-inline formats (not embedded below).

4FORM 4rdgdoc.xml
Open SEC.gov